Biogen | BIIB - Capitaux D'Emprunt

Prix De L'Action
195.18
Variation Quotidienne
11.80 6.43%
Mensuellement
4.06%
Annuel
61.20%
Q2 Prévisions
180.43




Capitaux D'Emprunt Changement Date
AbbVie USD 58.94B 4.03B 2025-12
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 285.82M 639K 2024-09
Amgen USD 50B 2.43B 2025-12
Bayer EUR 31.83B 877M 2025-12
Biogen USD 6.29B 1.7M 2026-03
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 22.13B 6M 2025-12
Incyte USD 29.41M 785K 2026-03
Merck USD 39.97B 6B 2025-09
Moderna USD 610M 584M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 2.03B 193.22M 2025-12
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 13.84B 1.88B 2026-03
Sanofi EUR 15.72B 150.06M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03